As antibiotic resistance poses a growing threat to global health, researchers are actively exploring innovative antimicrobial therapies to address this challenge. This article provides an in-depth exploration of alternative strategies beyond antibiotics, including bacteriophage therapy, nanotechnology, probiotics, CRISPR-based approaches, peptide therapeutics and combination therapies. These cutting-edge developments hold promise in revolutionizing the way we combat bacterial infections, offering targeted and effective solutions. However, along with the potential benefits, the article also discusses regulatory challenges, ethical considerations and the need for a responsible approach to ensure the sustainable progress of these novel therapies. The exploration of innovative antimicrobial therapies provides a glimpse into the future of infectious disease management, where precision, specificity and synergy play key roles in safeguarding global public health.
HTML PDFShare this article
Journal of Antimicrobial Agents received 444 citations as per Google Scholar report
